BioNexus Gene Lab Corp. (BGLC) vs Baiya International Group Inc. (BIYA)

A side-by-side comparison of BioNexus Gene Lab Corp. and Baiya International Group Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BGLC vs BIYA

growth of $100 · dividends reinvested · last 2y
BGLC -57.6% (-34.9%/yr)BIYA -99.9% (-96.3%/yr)BGLC compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $1002026$42$0
BGLC BIYA

BGLC vs BIYA: by the numbers

  • •BIYA is the larger company ($4M vs $3M market cap).
  • •Both run net losses; BIYA's is the smaller (-57.85% vs -82.36% net margin).
  • •BIYA grew revenue faster over the past five years (7.30% vs -31.68% CAGR).

Metrics side by side

Valuation

MetricBGLCBIYA
P/S ratio0.99N/A
P/B ratio0.400.12

Profitability

MetricBGLCBIYA
Gross margin11.64%11.54%
Operating margin-42.54%-58.12%
Net margin-82.36%-57.85%
ROE-33.11%-41.52%
ROIC-32.71%-41.31%

Growth (annualized)

MetricBGLCBIYA
Revenue CAGR (5Y)-31.68%7.30%
Total return CAGR (5Y)-61.00%N/A

Frequently asked

Which has grown faster, BGLC or BIYA?
Over the past five years, BIYA grew revenue faster — BGLC at a -31.68% CAGR versus BIYA at 7.30%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.